• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

控释给药系统中的微孔表面:使用非离子表面活性剂作为致孔剂设计和评价盐酸地尔硫卓控释渗透泵。

Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former.

机构信息

Drug Applied Research Center .

出版信息

Pharm Dev Technol. 2014 Jun;19(4):507-12. doi: 10.3109/10837450.2013.805774. Epub 2013 Jun 13.

DOI:10.3109/10837450.2013.805774
PMID:23763379
Abstract

The major problem associated with conventional drug delivery systems is unpredictable plasma concentrations. The aim of this study was to design a controlled porosity osmotic pump (CPOP) of diltiazem hydrochloride to deliver the drug in a controlled manner. CPOP tablets were prepared by incorporation of drug in the core and subsequent coating with cellulose acetate as semi-permeable membrane. Non-ionic surfactants were applied as pore-formers as well. The effect of pore-formers concentration on the in vitro release of diltiazem was also studied. The formulations were compared based on four comparative parameters, namely, total drug released after 24 h (D24 h), lag-time (tL), squared correlation coefficient of zero order equation (RSQzero) and mean percent deviation from zero order kinetic (MPDzero). Results of scanning electron microscopy studies exhibited formation of pores in the membrane from where the drug release occurred. It was revealed that drug release rate was directly proportional to the concentration of the pore-formers. The value of D24 h in the formulations containing Tween 80 (10%) and Brij 35 (5%) were found to be more than 94.9%, and drug release followed zero order kinetic (RSQzero > 0.99 and MPDzero < 8%) with acceptable tL (lower than 1 h).

摘要

与传统药物传递系统相关的主要问题是不可预测的血浆浓度。本研究旨在设计一种盐酸地尔硫卓的控释渗透泵(CPOP),以控制方式输送药物。CPOP 片剂通过将药物掺入芯部并用醋酸纤维素作为半渗透膜进行后续包衣来制备。非离子表面活性剂也用作造孔剂。还研究了造孔剂浓度对盐酸地尔硫卓体外释放的影响。根据四个比较参数,即 24 小时后释放的总药物(D24h)、滞后时间(tL)、零级方程的平方相关系数(RSQzero)和零级动力学的平均百分比偏差(MPDzero)对配方进行了比较。扫描电子显微镜研究的结果表明,在膜中形成了从其中释放药物的孔。结果表明,药物释放速率与造孔剂的浓度成正比。含有吐温 80(10%)和 Brij 35(5%)的制剂中 D24h 的值超过 94.9%,并且药物释放遵循零级动力学(RSQzero>0.99 和 MPDzero<8%),具有可接受的 tL(低于 1 小时)。

相似文献

1
Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former.控释给药系统中的微孔表面:使用非离子表面活性剂作为致孔剂设计和评价盐酸地尔硫卓控释渗透泵。
Pharm Dev Technol. 2014 Jun;19(4):507-12. doi: 10.3109/10837450.2013.805774. Epub 2013 Jun 13.
2
The effect of pore-formers and plasticizers on the release kinetic of diltiazem hydrochloride from the controlled porosity osmotic pumps.成孔剂和增塑剂对盐酸地尔硫䓬从控孔渗透泵中释放动力学的影响。
Drug Res (Stuttg). 2013 Aug;63(8):414-9. doi: 10.1055/s-0033-1343429. Epub 2013 Apr 18.
3
Micro-suspension coating method: a new approach in formulation and development of controlled porosity osmotic pump systems.微悬浮包衣法:控孔渗透泵系统制剂研发的新方法。
Drug Res (Stuttg). 2014 Apr;64(4):203-7. doi: 10.1055/s-0033-1355336. Epub 2013 Sep 11.
4
Development of an osmotic pump system for controlled delivery of diclofenac sodium.用于双氯芬酸钠控释的渗透泵系统的开发。
Drug Discov Ther. 2012 Oct;6(5):269-77.
5
Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.盐酸曲马多每日一次控释微孔渗透泵的研制与评价
AAPS PharmSciTech. 2016 Oct;17(5):1248-60. doi: 10.1208/s12249-015-0463-1. Epub 2015 Dec 17.
6
A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.一种通过孔隙渗透泵调节溶解度的新型颗粒,用于控制卡维地洛的递送。
Pharm Dev Technol. 2012 Nov-Dec;17(6):666-76. doi: 10.3109/10837450.2011.565348. Epub 2011 Apr 13.
7
[The delivery mechanism of micro-porous osmotic pump tablets].[微孔渗透泵片的释药机制]
Yao Xue Xue Bao. 2007 Feb;42(2):226-30.
8
Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.体外多孔不对称膜胶囊的配方与释药行为实验。
Drug Dev Ind Pharm. 2012 Jun;38(6):670-8. doi: 10.3109/03639045.2011.611809. Epub 2012 Apr 3.
9
Nano-suspension coating as a technique to modulate the drug release from controlled porosity osmotic pumps for a soluble agent.
Colloids Surf B Biointerfaces. 2017 May 1;153:27-33. doi: 10.1016/j.colsurfb.2017.02.007. Epub 2017 Feb 8.
10
Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.用于结肠特异性给药系统的壳聚糖基控孔渗透泵:制剂变量筛选及体外研究
Int J Pharm. 2007 Mar 6;332(1-2):115-24. doi: 10.1016/j.ijpharm.2006.09.038. Epub 2006 Sep 29.

引用本文的文献

1
In vitro, ex vivo and in silico mechanistic elucidation of the performance of an optimized porosity-controlled multi-elemental transbuccal system.优化孔隙率控制的多元素经颊给药系统性能的体外、离体和计算机模拟机制阐释
Pharm Res. 2015 Jul;32(7):2384-409. doi: 10.1007/s11095-015-1631-4. Epub 2015 Jan 29.